PharmaBiome AG Revenue and Competitors
Estimated Revenue & Valuation
- PharmaBiome AG's estimated annual revenue is currently $1.9M per year.
- PharmaBiome AG's estimated revenue per employee is $155,000
Employee Data
- PharmaBiome AG has 12 Employees.
- PharmaBiome AG grew their employee count by 0% last year.
PharmaBiome AG's People
Name | Title | Email/Phone |
---|
PharmaBiome AG Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $16.1M | 104 | 28% | N/A | N/A |
#2 | $37.4M | 511 | -2% | $250.2M | N/A |
#3 | $60.3M | 389 | -5% | N/A | N/A |
#4 | $31.8M | 205 | 22% | N/A | N/A |
#5 | $1.9M | 12 | 0% | N/A | N/A |
#6 | $2.5M | 16 | -43% | N/A | N/A |
#7 | $7.9M | 51 | 2% | N/A | N/A |
#8 | $1.1M | 7 | 17% | N/A | N/A |
#9 | $0.6M | 4 | 0% | N/A | N/A |
#10 | $10.4M | 67 | 81% | N/A | N/A |
What Is PharmaBiome AG?
PharmaBiome is a pre-clinical microbiome company that combines deep scientific expertise in microbiome microbiology, biotechnology and the molecular disease mechanisms. Based on our research, we believe that the common denominator underlying each intestinal microbiome is a network of interconnected, interdependent and essential metabolic functions for the host and the microbiome. Pharmabiome has developed unique technologies to access these functional groups of bacteria and then design and produce functional consortia at scale. PharmaBiome is a spinoff from ETH Zurich and has been recognized with increasing numbers of awards based on its advances with lead therapeutic consortia in the fields of IBD, oncology and graft versus host disease.
keywords:N/AN/A
Total Funding
12
Number of Employees
$1.9M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1M | 12 | 0% | N/A |
#2 | $1M | 12 | -40% | N/A |
#3 | $1M | 12 | -37% | N/A |
#4 | $1.6M | 12 | 0% | N/A |
#5 | $3M | 12 | 0% | N/A |